VantAI

Industry

  • Pharmaceuticals
  • Digital Health
    • Artificial Intelligence
  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • ADMET
See more in Biomedtracker

Latest on VantAI

In Vivo

Major AI-Pharma Partnerships And Investments Of 2024: A Strategic Overview

 
• By David Wild

Artificial intelligence was more than a buzzword in 2024; it shaped pharmaceutical industry investments throughout the year, with multiple billion-dollar partnerships and acquisitions across the drug

Scrip

Takeda Goes In On Molecular Glue Degraders With Degron Deal

 
• By Jessica Merrill

Takeda Pharmaceutical Co. Ltd. is the latest in a string of pharmaceutical manufacturers investing in molecular glue degraders through dealmaking. The company announced a collaboration with Shanghai-

Scrip

Deal Watch: Bristol To Link Up With VantAI On Molecular Glue Therapies

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr

Scrip

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets 5T4-Targeted NK Cell Therap